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Immunopathology and Infectious Diseases
COP9-Associated CSN5 Regulates Exosomal Protein
Deubiquitination and Sorting
Yuelong Liu,* Spandan V. Shah,* Xiaoyu Xiang,*
Jianhua Wang,* Zhong-bin Deng,* Cunren Liu,*
Liming Zhang,* Jianming Wu,* Tara Edmonds,§
Christina Jambor,¶ John C. Kappes,†‡§¶
and Huang-Ge Zhang*†
From the Division of Clinical Immunology and Rheumatology,*
and the Departments of Medicine,‡ Pathology,§ Microbiology,¶
and Pharmacology, University of Alabama at Birmingham,
Birmingham; and the Birmingham Veterans Administration
Medical Center,† Birmingham, Alabama
Ubiquitinated endosomal proteins that are deposited
into the lumens of multivesicular bodies are either
sorted for lysosomal-mediated degradation or se-
creted as exosomes into the extracellular milieu. The
mechanisms that underlie the sorting of cellular
cargo proteins are currently unknown. In this study,
we show that the COP9 signalosome (CSN)-associated
protein CSN5 quantitatively regulated proteins that
were sorted into exosomes. Western blot analysis of
exosomal proteins indicated that small interfering
(si)RNA knockdown of CSN5 results in increased lev-
els of both ubiquitinated and non-ubiquitinated exo-
somal proteins, including heat shock protein 70, in
comparison with exosomes isolated from the super-
natants of 293 cells transfected with scrambled siRNA.
Furthermore, 293 cells transfected with JAB1/MPN/
Mov34 metalloenzyme domain-deleted CSN5 pro-
duced exosomes with higher levels of ubiquitinated
heat shock protein 70, which did not affect non-ubiq-
uitinated heat shock protein 70 levels. The loss of
COP9-associated deubiquitin activity of CSN5 also led
to the enhancement of HIV Gag that was sorted into
exosomes as well as the promotion of HIV-1 release,
suggesting that COP9-associated CSN5 regulates the
sorting of a number of exosomal proteins in both a
CSN5 JAB1/MPN/Mov34 metalloenzyme domain-de-
pendent and -independent manner. We propose that
COP9-associated CSN5 regulates exosomal protein
sorting in both a deubiquitinating activity-dependent
and -independent manner, which is contrary to the
current idea of ubiquitin-dependent sorting of pro-
teins to exosomes. (Am J Pathol 2009, 174:1415–1425;
DOI: 10.2353/ajpath.2009.080861)
Cells receive information from the microenvironment and
pass the information from the cell surface to internal
compartments, from one compartment to another, and
even from cell to cell. Exosomes packed with a number of
proteins and RNAs deliver messages to the recipient
cells and execute their role in cell–cell communica-
tion.1–3 Therefore, the machinery for sorting exosome
molecules determines the composition of exosomes and
the subsequent biological effects on recipient cells. The
endosomal sorting pathway controls a variety of cellular
processes and plays a role in the sorting of ubiquitinated
cargo proteins into the lumen of multivesicular bodies
(MVBs)4 and viral budding.5–7 Ubiquitinated proteins are
recognized on the endosomal membrane and sorted, which
results in either MVB fusion with the lysosome to degrade its
contents,8,9 or releasing the contents into the extracellular
environment via exosomal vesicles.10 Released exosomes
can be taken up by neighboring cells or distant cells as a
means to pass information between cells. The exosome
pathway could also be hijacked by certain viruses, such as
HIV, to escape host immune recognition.5,6
The mechanism underlying the regulation of a protein
to be degraded in the lysosomal pathway or packed into
the exosomes for budding out of cells is not clear. Data
published recently support the idea that incorporation of
proteins into exosomes seems to be a selective and
regulated process.10 Ubiquitinated proteins may be deu-
biquitinated before or after sorting into the MVB and
before their actual incorporation into luminal vesicles or
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exosomes. Ubiquitinated proteins may also escape de-
ubiquitination and end up in exosomes. During this pro-
cess, deubiquitinating enzymes may work against E3-
ligase activity so as to regulate exosomal protein stability
and thus its biological activity. Deubiquitinating enzymes
might be recruited early in the pathway where they could
provide a proofreading mechanism and rescue cargo
before commitment to the degradation pathway or exo-
somal pathway. Therefore, deubiquitination versus ubiq-
uitination of exosomal proteins could be regulated by
deubiquitin enzymes that have not been identified.
CSN5 is identical to the fifth component of the COP9
signalosome complex (CSN), which is well conserved in
species from yeast to humans, and is involved in a variety
of biological responses, such as DNA metabolism, apo-
ptosis, checkpoint control, DNA repair, and cell cycle
control in various organisms.11–20 The CSN core is com-
posed of eight subunits (CSN1-8),20 and associates with
different types of proteins including kinases, ligases, and
adaptor proteins. CSN is also related structurally and
architecturally to the lid subcomplex of the 26S protea-
some that mediates degradation of ubiquitin-conjugated
proteins.21 Recent reports show that the Rpn11 subunit of
the proteasome lid subcomplex possesses ubiquitin
isopeptidase activity that is responsible for depolymer-
ization of the ubiquitin chains from substrates before
protein degradation.22,23 Likewise, the CSN5 subunit of
COP9, which shares sequence similarity to Rpn11, has
been shown to have isopeptidase activity that deconjugates
NEDD8 from cullin-NEDD8.24 CSN-mutations lead to defi-
cient NEDD8-deconjugating activity and accumulation of
NEDD8-conjugated cullins.24–26 Thus, CSN could serve as
a negative regulator of ubiquitin ligase activity by deconju-
gating NEDD8 from cullin-NEDD8.
Here, we demonstrate that COP9-associated CSN5
has ubiquitin isopeptidase activity, and regulates ubiq-
uitin-dependent protein sorting into exosomes. Further-
more, experiments with a mutant CSN5 indicate that the
CSN5-associated deubiquitin activity contributes to de-
conjugation of ubiquitin on exosomal proteins. Deletion of
the JAB1/MPN/Mov34 metalloenzyme (JAMM) domain of
CSN5 leads to the enhancement of ubiquitinated protein,
eg, HSP70 and HIV Gag, sorting into exosomes. More
ubiquitinated HIV Gag sorted into exosomes also corre-
lates with increased release of HIV-1 from infected cells.
Taken together these results indicate that COP9-associ-
ated CSN5 deubiquitin activity regulates the sorting of
exosomal proteins, and thus enhancement or attenuation
of COP9-associated CSN5 deubiquitin activity that might
lead to changes in the biological effects exosomes would
have on recipient cells. In addition, CSN5 also plays a
role in sorting non-ubiquitinated proteins into exosomes
in a JAMM domain-independent manner.
Materials and Methods
Cells
The 293 cells with a doxytetracycline inducible siRNA
CSN5 were cultured in complete modified Dulbecco me-
dium (Invitrogen, Carlsbad, CA) supplemented with exo-
some depleted 10% fetal bovine serum as described
previously.24 A control 293 cell line was established by
transfection of 293 cells with a control vector pGC95
(control scrambled siRNA, 5-CGTGCAAGGTCAGTACA-
TGTTCAAGAGACATGTACTGACCTTGCACG-3). To in-
duce siRNA expression, 293 cells were fed with doxytet-
racycline (1.3 g/ml in modified Dulbecco medium)24
and analyzed for the presence of CSN5 by Western blot.
MDA-MB-231 cells originally derived from a pleural effu-
sion were obtained from the American Type Culture Col-
lection (Manassas, VA) and were routinely cultured in
RPMI 1640 supplemented with 10% fetal bovine serum.
4T1 and TS/A mouse mammary carcinoma cell lines were
cultured using a method as described previously.27
CSN5 Plasmid DNA Constructs
A pGEX-CSN5 construct was generated by PCR amplifica-
tion from the pcDNA3-CSN5 template,19 using forward
primer 5-TTGTTGGGATCCATGGCGGCGTCCGGGAGC-
GGTAT-3 and reverse primer 5-CTATTAGAATTCTTAA-
GAGATGTTAATTTGATT-3 (BamHI and EcoRI restriction
sites are underlined). The pGEX-CSN5 construct was
generated by ligating annealed primers in-frame into
BamHI-EcoRI digested pGEX-2T vector (Amersham Bio-
sciences). Sequencing of plasmids was performed using
an ABI sequencer (Applied Biosystems, Foster City, CA).
BL21 competent E. coli cells (Stratagene) were trans-
formed with the pGEX-CSN5 construct. For large-scale
induction of glutathione S-transferase (GST)-CSN5 pro-
tein, an overnight culture was diluted 1:100 in 1 L Luria-
Bertani broth with appropriate antibiotics and cultured for
3 hours at 37°C. GST fusions were induced with 1 mmol/L
isopropyl -D-1-thiogalactopyranoside for 3 hours at
37°C. The cells were resuspended in 25 ml PBS with 1%
Triton X-100 and 0.8 mmol/L phenylmethylsulfonyl fluo-
ride, pulse-sonicated 4 minutes on ice and centrifuged at
10,000  g for 20 minutes at 4°C. Crude bacterial lysate
supernatant was purified using a Glutathione Sepharose
4B slurry (Amersham Biosciences). CSN5 protein purity
and integrity after purification were confirmed by Western
blotting. Protein concentration was determined using a
bicinchoninic acid protein assay kit (Pierce Biotechnol-
ogy, Rockford, IL).
Plasmids, including pLEYFP-CSN5, pLEYFP-CSN5JA-
MMDN expressing CSN5-YFP, YFP-CSN5-JAMM-DN, were
produced by subcloning human XhoI-HindIII fragment of
pcDNA3-CSN5 containing CSN5 into BglII-HindIII sites of
pLEYFP (Clontech) mammalian expression vectors. The
expression of fusion proteins of YFP-CSN5 was verified
by Western blot analysis for CSN5. The deletion of CSN5
JAMM domain between amino acid positions 53 to 85 in
pLEYFP-CSN5 was accomplished using a PCR tech-
nique and standard cloning techniques as described
previously.28
CSN5 with point mutations at amino acid positions 138
and 140 was generated as described previously29 and both
mutations replaced histidines with alanines. The CSN5
gene was cloned into the retroviral packaging vector
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pMSCVhyg (Clontech,Mountain View,CA). pcDNA3-HIVGag-
green fluorescent protein (GFP) was provided by Dr.
Stephen J. Gould and described previously.5 All plasmid
DNAs described above were used for transfection of 293
cells purchased from ATCC (Manassas, VA). Transfec-
tions were performed using the Lipofectamine 2000
method as described previously.19
Western Blot Analysis
Western blot analysis of exosomal proteins was done
using a method described previously.27 In brief, exo-
somes were boiled in SDS sample buffer, and total pro-
tein was loaded into each well of an SDS gel for separa-
tion by polyacrylamide gel electrophoresis (PAGE). After
electrophoresis, the proteins were then stained in the
gels using a Colloidal Blue Staining Kit (Invitrogen) or
transferred onto nitrocellulose membranes, and the blot-
ted membranes blocked with PBS-Tween 20 (0.25 M/L
Tris, pH 7.5, PBS, 150 mmol/L sodium chloride, and
0.2% Tween 20) containing 5% bovine serum albumin.
Blots were then probed overnight with 1 g/ml of a
primary antibody, washed three times with PBS-Tween
20 and then probed for 1 hour with the appropriate
Alexa Fluor 680 (Molecular Probes) or IRdye 800
(Rockland Immunochemicals) conjugated secondary
antibody. After three washes with PBS-Tween 20, blotted
proteins were detected and quantified using an Odyssey
infrared imaging system (LI-COR, Lincoln, Nebraska).
Exosome Purification
Exosomes were recovered from the supernatant of
cells cultured for 36 hours in depleted medium (ie,
exosome depleted fetal bovine serum; accomplished
by overnight centrifugation at 100,000  g). Exosomes
were purified by differential centrifugation using a pre-
viously described method.27 After differential centrifu-
gation, exosomes were sedimented by centrifugation
and were resuspended in PBS and re-sedimented at
70,000 g. Sedimented exosomes were resuspended in
5 ml of 2.6 M/L sucrose, 20 mmol/L Tris-HCl, pH 7.2, and
floated into an overlaid linear sucrose gradient (2.0 to
0.25 M/L sucrose, 20 mmol/L Tris-HCl, pH 7.2) in an
SW41 tube and centrifuged for 16 hours at 270,000  g
to remove non-membranous protein (complexes). Gradi-
ent fractions (1 ml) were collected via the bottom of the
tube and washed with PBS by centrifugation at 70,000 
g for 1 hour. Finally, the exosomes (fraction 3) were
resuspended in PBS. The morphology of exosomes was
examined by electron microscopy using a method de-
scribed previously.27 The protein content of the exosomes
was determined using a BCA protein assay kit (Bio-Rad,
Hercules, CA).
Immunoprecipitation and Antibodies
293 Cells were lysed by boiling the cells in 150 l SDS
lysis buffer (1% SDS, 150 mmol/L NaCl, 50 mmol/L Tris,
pH 8.0) for 10 minutes at 95°C. The lysate was diluted to
match the radioimmunoprecipitation assay (RIPA) buffer
concentrations (0.1% SDS, 1% Triton X-100, 0.5% so-
dium deoxycholate, 150 mmol/L NaCl, 50 mmol/L Tris, pH
8.0). After sonication, the lysate was cleared by centrifu-
gation for 10 minutes at 17,000 x g, and 100 l of diluted
primary antibody or a control nonimmune IgG coupled to
protein G-agarose beads added to the cleared lysate
supernatant. After four washes with washing buffer
(Pierce, Rockford, IL), the protein complexes were eluted
with 100 l of 0.1 mol/L glycine (pH 2.8) and collected.
The samples were mixed with sample buffer containing
2% -mercaptoethanol, heated to 95°C, centrifuged at
5000  g for 5 minutes and the supernatant subjected to
10% SDS-PAGE. The proteins in the gels were either
transferred to a nitrocellulose membrane (Bio-Rad) fol-
lowed by Western blot analysis or colloidal blue-stained
for liquid chromatography-tandem mass spectrometry
identification using a method described previously.27 The
following antibodies were used for immunoprecipitation
and Western blots: anti-ubiquitinated protein monoclonal
antibody (clone FK2, which recognizes mono- and polyu-
biquitinylated proteins, but not free ubiquitin, MBL, Woburn,
MA), anti-ß-actin (1:5000, Sigma, St. Louis, MO), CSN5,
(1:1000; Santa Cruz Biotechnology), rabbit anti-human
CD63 (1:500; Santa cruz biotechnology, Santa Cruz, CA),
anti-HSP70 (1:1000; Santa cruz biotechnology), anti-
CSN1–8 sampler kit (1:500; Boston Biochemicals), anti-
GFP antibody (Clontech), and anti-HIV Gag antibody.
In Vitro Deubiquitination Assay
Exosomes were sonicated in deubiquitination buffer (50
mmol/L Tris-HCl, pH 7.2 or pH 8.3, 25 mmol/L KCl, 5
mmol/L MgCl2, 1 mmol/L dithiotrheitol). The deubiquitina-
tion reaction was performed in a 37°C water bath for 30 or
60 minutes, and the reaction stopped in a 4°C ice bath for
10 minutes, followed by addition of 1 SDS sample
buffer.
Quantification of HIV-1 Released in the Cultured
Supernatants of 293 Cells
To analyze the effect of CSN5 on HIV-1 exosomal release,
the pNLENG1-ES-IRES proviral DNA was used. NLENG1-
ES-IRES represents a recombinant HIV-1 proviral DNA
that expresses GFP subsequent to infection and proviral
DNA integration. NLENG1-ES-IRES was constructed and
has the characteristics of YFP and CFP reporter viruses
reported by Levy et al.30 The NLENG1-ES-IRES construct
is replication defective since it does not express enve-
lope glycoprotein (gp160). Infectious virus stocks were
generated by cotransfecting 293T cells with NLENG1-ES-
IRES plus the vesicular stomatitis virus G protein expres-
sion plasmid, and used to infect 293 cells stable trans-
fected with either CSN5 pLEYFP-CSN5-JAMMDN or
pLEYFP-CSN5. Eight hours postinfection, the cells were
washed twice with complete medium to remove the ex-
cess virus. Fresh medium was added to each well. Two
hours after washing, the residual virus, as determined by
detecting p24 using an enzyme-linked immunosorbent
CSN5 Regulates Exosome Protein Sorting 1417
AJP April 2009, Vol. 174, No. 4
Figure 1. siRNA knockdown of CSN5 increases ubiquitination of exosomal proteins. A: Exosomes were analyzed by Western blotting using a monoclonal
antibody, anti-CSN5, and rabbit polyclonal antibodies to CSN1, 3, and 8, of COP9. Exosome markers, including CD63 and Tsg101, were also analyzed. 293 cells
stably transfected with pGC93 (siRNA CSN5 expression vector) or 293 cells transfected with scrambled siRNAs were treated with doxytetracycline (1.3 g/ml) over
a 5-day period. The cells were then used for the following experiments (B through F). In other experiments, 293 cells stably transfected with either pGC93 or
scrambled siRNA were transfected with pcDNA3-HIVGag-GFP before being treated with doxytetracycline and subsequently used in experiment G. B: Exosomes
were purified from supernatants using sucrose gradients and analyzed by electron microscopy (scale bar  200 nm). The micrograph is representative of two
independent experiments. C: Fifty g of total cell lysate from 293 cells pretreated with doxytetracycline over 5 days were loaded on 10% SDS gels for PAGE
separation. The separated proteins were transferred to a nitrocellulose membrane for Western blotting and probed using antibodies as indicated in Figure 1C.
Representative Western blots are shown. D: Fifty g of protein extracted from exosomes isolated from the supernatants of 293 cells (lanes 1 and 2) or total cell
lysates (lanes 3 and 4) were used for ubiquitin Western blot analysis. -actin detection served as a control for Western blotting analysis. E: Five-day doxytetracycline
treated 293 cells (E, panels 3 and 4) or exosomes (E, panels 1 and 2) isolated from the supernatants of 293 cells were lysed using immunoprecipitation lysate buffer.
Immunoprecipitation assays were performed using 500 g aliquots of the total protein lysates and an anti-ubiquitin monoclonal antibody (E, panels 1 and 3) or
mouse IgG as a control (E, panels 2 and 4). Precipitated proteins were run in western blots probed with anti-CD63 and anti-HSP70. The presence of HSP70
(F, top panel) and CD63 (F, bottom panel) were determined by Western blot analysis of exosomes purified from the same 293 cells as described above.
G: The presence of HIV Gag (top panel) and CD63 (bottom panel) in exosomes purified from 5-day doxytetracycline treated 293 cells were determined
by Western blot analysis. Data presented in A–D represent three independent experiments that yielded similar results. The signal intensity of each protein
analyzed in E–G was quantified using an Odyssey infrared imaging system (LI-COR). The ratios of signal intensity of each protein in exosomes of CSN5
siRNA: scramble siRNA knockdown 293 cells were calculated and plotted (E–G, bar graphs). The data are presented as means of three independent
experiments.
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assay (ELISA), was at an undetectable level in the super-
natants (data not shown). Forty-eight hours postinfection,
culture supernatants were collected from each well and
analyzed by HIV-1 p24 antigen ELISA (Perkin Elmer). The
infected cells were quantified by fluorescence-activated
cell sorting analysis for GFP-positive cells using a method
as described previously.31
Statistics
Results were expressed as means SD, and assessed by
one-way analysis of variance with Bonferroni correction.
Results
CSN5 Regulates Exosomal Protein
Ubiquitination and Sorting
Ubiquitination/deubiquitination of proteins plays an im-
portant role in sorting a protein into exosomes via the
MVB pathway. Exosomal proteins have been demon-
strated to be ubiquitinated.32 To determine whether
CSN5, which possesses a potential deubiquitin domain,
is recruited into exosomes, exosomes isolated from the
supernatants of 293 cells and a human breast tumor cell
line (MDA-MB-231) were used for Western blot analysis
of proteins using the antibodies indicated in Figure 1A.
COP9-associated CSN5 was detected in both human
tumor cell lines (Figure 1A) and also the murine breast
tumor cell lines 4T-1 and TS/A (data not shown), suggest-
ing that CSN5 may regulate exosomal protein ubiquitina-
tion and sorting. To determine whether CSN5 plays a role
in regulation of exosomal protein ubiquitination, CSN5 in
293 cells was inducibly knocked down by the addition of
doxytetracycline. Exosomes were purified from the su-
pernatants of 293 cells (Figure 1B, a representative im-
age is shown). Morphologically, there are no visible dif-
ferences in the shapes and sizes of the exosomes as a
result of depletion of CSN5 (Figure 1B). Western blot
analysis indicated that CSN5 was knocked down dramat-
ically at day 3 after the addition of doxytetracycline (1.3
g/ml) (Figure 1C, top panel) but not in 293 cells stably
transfected with a scrambled siRNA (Figure 1C, bottom
panel). Treatment of 293 cells with doxytetracycline alone
did not appear to have an effect on -actin expression
(Figure 1C, middle panel). The results of Western blot
analysis of ubiquitinated exosomal proteins demon-
strated a much higher concentration of ubiquitinated pro-
teins in the exosomes isolated from the supernatants of
293 cells transfected with siRNA CSN5 when compared
with control 293 cells (Figure 1D, lanes 1 and 2). Knock-
down of CSN5 does not seem to have an effect on ubiq-
uitination of total cellular proteins (Figure 1D, lanes 3 and
4). The increase in signal intensity of ubiquitinated pro-
teins in the exosomes isolated from the supernatants of
293 cells with CSN5 knockdown is not due to protein
loading on the gel because similar amounts of -actin
were detected in all test samples (Figure 1D, lanes 1 and
2 and the bottom panel). The difference in intensity of the
-actin signals when comparing exosomes and cell ly-
sates (Figure 1D, bottom panel) suggests that proteins in
exosomes are enriched in general (50 g/lane).
From three independent assays, immunoprecipitation
of ubiquitinated exosomal proteins followed by Western
blot analysis confirmed the presence of HSP70 and CD63
(Figure 1E). Interestingly, knockdown of CSN5 in 293
cells resulted in no changes in the amount of HSP70 from
total cell lysates (Figure 1E, third panel from the top)
whereas the amount of ubiquitinated HSP70 in the exo-
somes was remarkably increased (Figure 1E, the top
panel, right panel of bar graph). In contrast, the amount
of ubiquitinated CD63 sorting into exosomes was not
different from the amount present in cell lysates (Figure
1E, lanes 1 and 2). These results suggest that CSN5
selectively regulated the ubiquitination of certain exoso-
mal proteins. The specificity of ubiquitin immunoprecipi-
tation was supported by the fact that no signal was de-
tected for HSP70 or CD63 when a normal mouse IgG was
used for immunoprecipitation (Figure 1E, second and
fourth panels from the top).
Western blot analysis was done to determine whether
CSN5 regulates total HSP70 in addition to potentially
playing a role in sorting ubiquitinated HSP70 into exo-
somes, Western blot analysis of exosomal HSP70 indi-
cated that knockdown of CSN5 results in an increase of
HSP70 sorted into the exosomes (Figure 1F, top panel,
and right panel of bar graph). The fact that there was no
change in the exosomal CD63 signal (Figure 1F, bottle
panel) suggests that CSN5 also selectively regulates
exosomal protein sorting. Sorting of endogenously ex-
pressed HSP70 into exosomes is regulated by CSN5,
and in addition siRNA knockdown of CSN5 also results in
an increase of the transiently expressed HIV Gag sorted
into 293 exosomes (Figure 1G). Therefore, the result of
CSN5 regulating HIV Gag sorting into exosomes further
suggests that COP9 associated CSN5 may regulate more
than HSP70 sorting into exosomes.
Deubiquitination Activity of COP9-Associated
CSN5 Regulates HSP70 Ubiquitination
Since knockdown of CSN5 in 293 cells led to an increase
of HSP70 sorted into exosomes, and ubiquitination of
proteins is considered as a crucial step for sorting into
exosomes, we sought to determine whether CSN5 has
the deubiquitination activity to regulate HSP70 deubiqui-
tination, as a example. To perform this analysis, sucrose-
purified exosomes isolated from the supernatant of 293
cells with CSN5 knockdown were suspended in deubi-
quitination buffer. Sonicated exosomes were then used in
a deubiquitin reaction. The reaction was incubated at
37°C for 0, 30, and 60 minutes and stopped by addition
of 1% SDS. Immunoprecipitation of ubiquitin followed by
Western blot analysis of HSP70 provided evidence that
the addition of recombinant COP9 (Figure 2A, top panel)
to the exosomal complex led to significant deubiquitina-
tion of exosomal HSP70 (Figure 2A) after a 60 minutes
incubation as compared with a 0-minute incubation. The
signal intensity of ubiquitinated HSP70 when recombi-
nant CSN5 alone was added was not different from the
CSN5 Regulates Exosome Protein Sorting 1419
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signal intensity of ubiquitinated HSP70 in a PBS control
sample. This finding suggests that the COP9 complex,
not CSN5 alone is required for its deubiquitination activ-
ity. The reduction of signal intensity of ubiquitinated
HSP70 is not due to unequal loading of amounts of
HSP70 precipitate used for the deubiquitination assay
because similar amounts of HSP70 were detected in all
samples before the reaction (Figure 2, A and B, bottom
panels). Control samples (Figure 2, A and B, middle
panels) did not have detectable signal, indicating the
specificity of the anti-HSP70 reaction. In summary, the
data presented in Figure 2A, and Figure 1D suggest that
exosomal COP9 associated CSN5, by virtue of its deubi-
quitination activity, plays a role in the regulation of exo-
somal protein ubiquitination.
CSN5 JAMM Domain Regulates Exosomal
Protein Deubiquitination
Although CSN5 is involved in removal of NEDD8 from
modified proteins as a means to regulate protein activity,
the role of CSN5 for the removal of ubiquitin from in vivo
ubiquitinated proteins has not been demonstrated in
mammalian cells. Given that ubiquitin and NEDD8 have
closely related structures,33 we examined whether the
JAMM domain of CSN5 plays a role in the ubiquitin
isopeptidase of exosomal proteins. 293 cells were stably
transfected with the following vectors: pLEYFP-CSN5,
pLEYFP-CSN5-JAMMDN, or pLEYFP. Western blot anal-
ysis of CSN5 expression in the transfected cell lines
indicated that the fusion proteins YFP-CSN5 (Figure 3A,
Lane 1) and YFP-CSN5-JAMMDN (Lane 2) could be de-
tected, and that the expression of the fusion protein does
not have an effect on the amount of endogenous CSN5
(Figure 3A, bottom protein in each lane). Western blot
analysis of immunoprecipitated ubiquitin exosomal pro-
teins indicated that deletion of the JAMM domain of CSN5
led to a significant increase in the ubiquitination of exo-
somal HSP70, as compared with the exosomes isolated
from 293 cells transfected with wild-type pLEYFP-CSN5
(Figure 3B, the top panel, and right panel of bar graph).
In contrast, ubiquitinated exosomal CD63 was not af-
fected (Figure 3B, third panel). The signals detected are
ubiquitinated-specific as there is no signal detected
when a control mouse IgG was used in the assay (Figure
3B, second and fourth panels). The deletion of CSN5
JAMM domain does not appear to have an effect on the
ubiquitination of total cellular protein (Figure 3C). Unlike
siRNA knockdown of total CSN5 as shown in Figure 1F,
deletion of CSN5 JAMM domain does not appear to
increase non-ubiquitinated HSP70 sorted into the exo-
somes (Figure 3D).
Ubiquitination of HIV Gag occurs when HIV hijacks the
exosomal pathway.34–38 To examine the role of deubiqui-
tination activity of CSN5 in HIV Gag ubiquitination, ubiq-
uitination of HIV Gag was determined in 293 cells stably
transfected with pLEYFP expressing CSN5 with/without
the JAMM domain deletion plus pcDNA3-HIVGag-GFP
(Figure 3, E and F, left panels) or pcDNA3 (Figure 3, E
and F, right panels) as controls. The results of ubiquitin
immunoprecipitation followed by Western blot analysis of
GFP (Figure 3E,) or HIV Gag (Figure 3F) indicates that
more ubiquitinated Gag was detected in exosomes iso-
lated from 293 cells transfected with the JAMM domain
deleted CSN5 than cells transfected with wild-type. The
signal detected was GFP or Gag specific as no signal
was detected when 293 cells were transfected with
pcDNA3 instead of pcDNA3-HIVGag-GFP (Figure 3, E
and F, right panels). In addition, the identity of each band
detected (Figure 3E, left panel) was also confirmed by
mass spectrometry. These bands were identified as ubi-
quitinated HIV Gag (data not shown). The reduction of
Figure 2. COP9 associated CSN5 regulates the deubiquitination of exosomal
proteins. One microgram of a COP9 complex (A, lanes 1, 2, and 3, labeled 0,
30, and 60, respectively) was added to 500 g of sonicated exosomes isolated
from 293 cells transfected with pGC93 vector treated for 5 days with doxytet-
racycline (1.3 g/ml). One-third of the mixture was used for Western blot
analysis of HSP70 (A, bottom panel), and the remainder used in a deubiq-
uitin assay. A deubiquitin reaction was performed at 37°C for 0, 30, and 60
minutes. The reaction was stopped by addition of 1% SDS sample buffer and
subsequently run in an immunoprecipitation assay using agarose beads
conjugated to mouse anti-ubiquitin (A, top panel) or mouse IgG antibodies
(middle panel), followed by HSP70 Western blot analysis. Five hundred
micrograms of 293 cell exosomal protein, as described in (A) were used in a
deubiquitin assay in the presence of 1 g of recombinant COP9 (B, lane 1),
1 g of GST-CSN5 (B, lane 2), or PBS as a control. One-third of the reacted
proteins was used for Western blot analysis of HSP70 (B, bottom panel).
The remainder was used for the deubiquitin reaction conducted at 37°C for
1 hour. The deubiquitinated samples were used for ubiquitin (B, top panel)
or mouse IgG (B, middle panel) immunoprecipitation, and then Western-
blotted and probed with an anti-HSP70 antibody. One representative exper-
iment is presented, out of three independent experiments. The signal inten-
sity of each protein analyzed in A and B was quantified using an Odyssey
infrared imaging system (LI-COR). The ratios of signal intensity of ubiquiti-
nated HSP70 at 30 minutes and 60 minutes against 0 minutes after the
reaction was terminated were calculated and plotted (A, bar graph). The data
are presented as means of three independent experiments. Using a similar
method, the ratios of signal intensity of ubiquitinated HSP70 in the 60 minutes
reaction containing either GST-CSN5 or COP9 against PBS as a control were
calculated and plotted (B, bar graph). The data are presented as means of three
independent experiments. **P  0.0082 (2A); **P  0.0057 (2B).
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Figure 3. JAMM domain of CSN5 plays a role in the regulation of ubiquitination of exosomal proteins. A: 293 cells were transfected with different plasmid DNAs
(10 g) as indicated in Figure (A). Thirty-six hours after the transfection, the cells (1  106) were lysed in lysis buffer and 50 g of total protein from each lysate
were resolved on a 10% SDS gel by PAGE. The proteins were then transferred to a nitrocellulose membrane and the blots were probed with a mouse anti-CSN5
antibody. 293 cells were transfected with pLEYFP-CSN5 or pLEYFP-CSN5-JAMMDN for 36 hours. The exosomes isolated from the supernatants of transfected 293
cells were immunoprecipitated with an anti-ubiquitin monoclonal antibody, followed by Western blot analysis for HSP70 (B, top left panels) and CD63 (B,
bottom left panels). In other experiments, 293 cells were lysed and used for Western blot analyses of mono- or polyubiquinated proteins (C) or exosomes were
lysed and used for Western blot analysis (D). The exosomes isolated from the supernatants of 293 cells transfected with pLEYFP-CSN5 or pLEYFP-CSN5-JAMMDN
PLEYFP plus pcDNA3-HIVGag-GFP (E, left panel; F, top left panel) or plus pcDNA3 (E, right panel, F, right panel) were used for ubiquitin immunopre-
cipitation, followed by Western blot analysis of GFP (E) or Gag (F). An equal concentration of normal mouse IgG was used as a control for immunopre-
cipitation, followed by Western blot analysis of Gag (F, bottom left panel). 293 cells were transfected with pcDNA3.1-CSN5 or pcDNA3.1-CSN5Mut for
36 hours. The sucrose purified exosomes were then run in immunoprecipitation assays using an anti-ubiquitin monoclonal antibody (G, panels 1 and 3)
or mouse IgG (G, panels 2 and 4). Western blot analysis of HSP70 (G, top left panels) and CD63 (G, bottom left panels) followed. The signal intensity
of each protein analyzed in (B, D–F, and G) was quantified using an Odyssey infrared imaging system (LI-COR). The ratios of signal intensity of each protein
in exosomes of 293 cells stably transfected with CSN5JAMMDN : CSN5 genes (B, D, E, and F, bar graphs) and CSN5Mut:CSN5 genes (G, bar graph) were
calculated and plotted. The data are presented as means of three independent experiments.
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signal intensity of ubiquitinated HIV Gag in the exosomes
isolated from the supernatants of 293 cells transfected
with wild-type CSN5 is not due to insufficient expression
of HIV Gag-GFP because similar amounts of Gag were
detected in both cellular lysates (Figure 3F, bottom/left
panel). We also determined the amount of ubiquitinated
HIV Gag in exosomes isolated from the supernatants of
293 cells with/without CSN5 knocked down by the addi-
tion of doxytetracycline using the identical strategy as
described above. siRNA knockdown of CSN5 led to an
increase of ubiquitinated HIV Gag in 293 exosomes (data
not shown).
Within the JAMM domain of the CSN5 protein, amino
acids 138 and 140 have been shown to be critical for
maintaining deubiquitination of NEDD8 activity. To further
identify whether these two amino residues play a role in
CSN5-mediated deubiquitination of exosomal HSP70,
293 cells were transfected with wild-type CSN5 or mutant
CSN5 with both amino acid mutations. On Western blot
analysis of ubiquitinated exosomal HSP70, a stronger
signal was detected in the exosomes isolated from the
supernatants of 293 cells transfected with the mutations
than with a pcDNA3.1CSN5 control vector (Figure 3G).
These data suggest that the JAMM domain of CSN5
plays a role in the deubiquitination of exosomal HSP70.
Since HIV-1 Gag ubiquitination has been shown to be
important for virus formation, we further determined if the
JAMM domain of CSN5 has an effect on the release of
HIV-1 through the exosomal pathway, which represents
an important pathway of HIV-1 assembly and release in
certain cell types.39–42 ELISA data show that 48 hours
after cells are infected with HIV-1, there is a significant
increase in the amount of de novo produced virus re-
leased from 293 cells transfected with CSN5 JAMM do-
main deletion in comparison with 293 cells transfected
with a wild-type CSN5 (Figure 4).
Discussion
In this study, we have shown that COP9 associated CSN5
plays a role in exosomal proteins including HSP70 sorting
into the exosomes. Our data indicates that siRNA knock-
out of CSN5 causes a significant increase in both ubiqui-
tinated and non-ubiquitinated proteins including HSP70
detected in the exosomes but not in total cell lysates.
Second, we have shown that the JAMM domain of CSN5
has deubiquitin activity that regulates ubiquitinated
HSP70 sorting into exosomes. Third, knockdown of CSN5
led to the enhancement of ubiquitinated and total HSP70
sorted into exosomes, supporting the hypothesis that
CSN5 is a rate-limiting factor that controls protein sorting
into exosomes in a deubiquitin dependent and indepen-
dent manner. Finally, deletion or point mutation of CSN5
JAMM domain in 293 cells also leads to an enhancement
of ubiquitination of other protein, such as HIV Gag, that
was sorted into exosomes. This finding suggest that
COP9 associated CSN5 regulates other protein sorting
into exosomes in addition to HSP70 proteins.
Ubiquitination functions as a sorting signal for endo-
somes that directs ubiquitination substrates to the interior
of MVBs.8,43–45 This is the first step that leads to endo-
somes being transported to lysosomes. An alternative
fate of MVBs is their exocytic fusion with the plasma
membrane leading to the release of 50- to 90-nm vesi-
cles, called exosomes, into the extracellular milieu. In the
present study we observed that COP9-associated CSN5
regulates deubiquitination of exosomal proteins. Al-
though the exact site where exosomal protein sorting is
regulated by CSN5-associated COP9 deubiquitin activity
is unknown, it is significant that we identified that CSN5-
associated with COP9 possesses a deubiquitinase activ-
ity for exosomal proteins. Unlike Groisman et al’s find-
ing46 where an artificially polyubiquitinated Cul4A was
used as a substrate for in vitro deubiquitination, the pro-
teins we tested, ie, HSP70 and HIV Gag, are derived from
exosomes released from the producer cells as a sub-
strate and already demonstrate the deubiquitin activity
associated with CSN5. Therefore, our data likely repre-
sent what is taking place in vivo during exosome biogen-
esis. Moreover, since more than just exosomal HSP70 is
regulated by CSN5-associated COP9 deubiquitinase ac-
tivity, identification of other exosomal proteins regulated
by the deubiquitinase activity of the CSN5 should provide
an important clue to understanding why many pathways
regulated by CSN5 are associated with protein degrada-
tion. There are still many questions to be addressed. For
an example, CSN5 exists as two forms–a free form and a
COP9 associated form. We have shown that deubiquiti-
nase activity of CSN5 is associated with COP9. It would
be of interest to determine whether the JAMM motif
deleted mutant we tested in this study acts as a dom-
inant negative CSN5 to compete with endogenous
wild-type CSN5 for inhibition of its deubiquitin activity.
If this is the case, then we could theoretically design a
specific peptide that is the homologue with CSN5
Figure 4. 293 cells stably transfected with pLEYFP-CSN5-JAMMDN or
pLEYFP-CSN5 were infected with vesicular stomatitis virus G pseudotyped
HIV-1 NLENG1-ES-IRES. Forty-eight hours later, the cell culture supernatants
were analyzed for de novo produced virus by measuring HIV-1 capsid
protein using an ELISA for p24. The relative number of HIV-1 infected cells
in each culture (JAMMDN mutant versus wild-type) was determined by flow
cytometry, measuring NLENG1-ES-IRES/GFP cells (A). The ELISA results
are expressed as pg concentration of p24 released per GFP cell (B). Data
are given as the average values  SEM obtained for three samples in two
independent experiments. **P  0.001.
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JAMM domain so as to manipulate the CSN5-associ-
ated deubiquitin activity in vivo.
Through this study, we also noticed that unlike ubiq-
uitin patterns of the proteins extracted from total cellular
lysates, Western blot analysis of ubiquitinated exosomal
proteins, including exosomal HIV Gag, show that they are
discrete bands instead of smeared bands. Similar results
have been reported by other groups.32 The following
factors could contribute to these phenomena although
other explanations cannot be excluded. These exosomal
proteins may be: 1) dominantly mono-ubiquitinated or
polyubiquitinated; 2) initially sorted as polyubiquitinated
proteins, but during processing in the exosomal pathway,
they may be deubiquitinated so that only certain numbers
of ubiquitin moieties remaining attached; or 3) mono-
ubiquitinated proteins that are selectively enriched in the
exosomes whereas polyubiquitinated exosomal proteins
are not enriched and only the mono-ubiquitinated pro-
teins can be detected. Further investigations will need to
explore whether COP9 associated CSN5 preferentially
regulates mono-ubiquitinated versus polyubiquitinated
protein sorting into exosomes. This is of interest since
CSN5 associated COP9 has at least two distinct ubiquitin
isopeptidase activities: activities that deconjugate ubiq-
uitin and activities that depolymerize polyubiquitin.46
We have shown that COP9 associated CSN5 deubi-
quitination activity is not restricted to exosomal HSP70,
evidenced by the fact that sorting of HIV-ubiquitinated
Gag into exosomes is also regulated by CSN5. Knockout
of CSN5 resulted in more ubiquitinated Gag being de-
tected in the exosomes, and more p24 released in the
supernatants of 293 cells infected with HIV. Ubiquitina-
tion of Gag is essential for HIV assembly and bud-
ding.35,47–49 The amount of p24 released has been used
as a marker for virus maturation.40,41 Our result suggests
that CSN5 may be a rate-limiting factor for HIV release.
One possible mechanism underlying this phenomenon
would be that COP9-associated CSN5 deubiquitination
activity controls Gag ubiquitination. The ubiquitination of
Gag is essential for Gag transport/transfer into the endo-
somal pathway and subsequently allowing HIV to hijack
the exosomal pathway and to bud out of cells. Deubiqui-
tination activity of COP9-associated CSN5 could have an
effect on the availability of ubiquitinated HIV Gag in the
endosome compartment before HIV budding. CSN5 me-
diated deubiquitinated HIV Gag would be sorted into a
lysosomal pathway for degradation whereas ubiquiti-
nated Gag would be sorted into an exosomal pathway
that has been hijacked by HIV for its budding. Therefore,
deletion or mutation of CSN5 JAMM domain in 293 cells
resulted in more ubiquitinated Gag sorting into exo-
somes, which, in the end, may result in more viruses
being released.
In contrast, siRNA knockdown of CSN5 leads to an
increase of both ubiquitinated HSP70 and non-ubiquiti-
nated HSP70. Our findings indicate that deletion of the
CSN5 JAMM domain primarily has an effect on the
sorting of ubiquitinated HSP70, suggesting that CSN5
regulates not only ubiquitinated proteins but total pro-
tein sorted into exosomes as well. We do not know
which CSN5 domain(s) regulate total protein sorting
into exosomes.
Caution should be exercised in drawing conclusions
on the role of CSN5 in terms of deubiquitination of
exosomal proteins. CSN5 could directly or indirectly
regulate the deubiquitination of exosomal proteins.
CSN5 containing the deubiquitin domain with a point-
mutation or the CSN5 with a deletion of this domain could
result in a reduction of deubiquitination of exosomal pro-
teins. Therefore, CSN5 could act as a deubiquitin enzyme
to drive this reaction. Also plausible is that a deubiquitin
enzyme associated with CSN5 or other subunits of COP9
may initiate the reaction, and CSN5 regulates the activity
of its associated deubiquitin enzyme since COP9-asso-
ciated CSN5 interacts with many proteins and regulates a
variety of signaling pathways. Both possibilities could
co-exist. Mass spectrometry analysis of COP9-associ-
ated deubiquitin enzymes would be one avenue for de-
termining if the latter possibility is the case. Additionally,
siRNA knockdown of the COP9-associated deubiquitin
enzyme would provide conclusive evidence that the latter
possibility occurs.
It is conceivable that regulation of exosomal compo-
nents, including exosomal proteins in and out of an exo-
some, is critical for determining the biological effects on
recipient cells under physiological and pathophysiological
conditions. Our results point out that the composition of
exosomal proteins, such as HSP70 and HIV Gag, can be
regulated by manipulating the expression of CSN5 and
COP9/CSN5 associated deubiquitinase activity. CSN5 is
upregulated in the tumor tissues including breast, colon,
pancreatic, and lung carcinomas.50–59 CSN5 overexpres-
sion has been correlated with a poor cancer prognosis. Our
findings and other groups’ published results indicate that
exosomes released from tumor cells cause immune sup-
pression27,31,60,61; while other data suggest that tumor exo-
somes stimulate an immune response.62 This discrepancy
in exosomal protein activity and biological function could be
due to the level of expressed CSN5 in particular tumor cell
lines used in each study. This possibility is further validated
by our HIV production data, suggesting that CSN5 nega-
tively regulates the production of HIV particles. Interestingly,
recently published data report that CSN5 overexpression is
negatively correlated with hepatitis B virus infection in hep-
atocellular carcinoma patients.50 In summary, besides
CSN5 being an important factor in several signaling path-
ways, it may also regulate exosomal protein sorting and
may have other effects on exosome mediated cell-to-cell
communication, tumor immune suppression, and in the
pathogenesis of viral infections (including HIV).
The results presented in this study raise several ques-
tions and prompt new avenues of investigation. Future
studies should focus on the unique nature of COP9-
associated CSN5 deubiquitination activity, the role of
COP9-associated CSN5 machinery responsible for driv-
ing exosomal protein sorting, how this system functions in
relation to ESCRT components and how COP9-associ-
ated CSN5 selectively targets certain cargoes. Answers
to these issues will assist in clarifying the diverse func-
tions of COP9.
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